The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 89BIO INC | COM | 282559103 | BBG00QKDZ8J5 | 4,560,231 | 408,257 | SH | SOLE | 408,257 | 0 | 0 | ||
| AC IMMUNE SA | SHS | H00263105 | BBG00D0RHJ38 | 2,172,940 | 434,588 | SH | SOLE | 434,588 | 0 | 0 | ||
| ACELYRIN INC | COM | 00445A100 | BBG00YJKJ8H4 | 4,381,803 | 587,373 | SH | SOLE | 394,076 | 0 | 193,297 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | BBG001J2LL66 | 4,692,153 | 246,178 | SH | SOLE | 202,230 | 0 | 43,948 | ||
| AMBRX BIOPHARMA INC | COM | 641871108 | BBG0118LMRT6 | 1,795,678 | 126,101 | SH | SOLE | 126,101 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | BBG000PLF6N0 | 12,243,345 | 862,815 | SH | SOLE | 862,815 | 0 | 0 | ||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | BBG00DP10YT5 | 1,227,368 | 83,381 | SH | SOLE | 83,381 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | BBG0026ZDHR0 | 963,900 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| ANI PHARMACEUTICALS INC | COM | 00182C103 | BBG000KK1L04 | 4,707,963 | 85,382 | SH | SOLE | 85,382 | 0 | 0 | ||
| ANNEXON INC | COM | 03589W102 | BBG007QVDFG2 | 2,756,234 | 607,100 | SH | SOLE | 607,100 | 0 | 0 | ||
| APPLIED THERAPEUTICS INC | COM | 03828A101 | BBG000DD0489 | 3,038,959 | 907,152 | SH | SOLE | 649,599 | 0 | 257,553 | ||
| ARCELLX INC | COMMON STOCK | 03940C100 | BBG01K0YQHF7 | 283,465 | 623 | SH | Call | SOLE | 623 | 0 | 0 | |
| ARCELLX INC | COMMON STOCK | 03940C100 | BBG00QHJM4S9 | 17,405,022 | 313,604 | SH | SOLE | 282,067 | 0 | 31,537 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG00QN8K4M4 | 8,380,351 | 2,594,536 | SH | SOLE | 2,059,616 | 0 | 534,920 | ||
| ARGENX SE | CALL | 04016X901 | BBG00GHB88X9 | 10,075,308 | 26,484 | SH | SOLE | 26,484 | 0 | 0 | ||
| ARK ETF TR | GENOMIC REV ETF | 00214Q302 | BBG01KN9BR89 | 375,000 | 5,000 | SH | Put | SOLE | 5,000 | 0 | 0 | |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | BBG000BRVKH0 | 1,806,563 | 59,038 | SH | SOLE | 59,038 | 0 | 0 | ||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 1,349,400 | 230,273 | SH | SOLE | 230,273 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | BBG000QSGWX5 | 4,812,895 | 626,679 | SH | SOLE | 371,166 | 0 | 255,513 | ||
| AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | BBG00KVT05R6 | 2,906,855 | 451,375 | SH | SOLE | 358,700 | 0 | 92,675 | ||
| BIOHAVEN LTD | COM | G1110E107 | BBG017BXV3Q9 | 4,765,951 | 111,354 | SH | SOLE | 111,354 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | BBG00P9KDZK6 | 10,251,881 | 253,948 | SH | SOLE | 253,948 | 0 | 0 | ||
| CABALETTA BIO INC | COM | 12674W109 | BBG00MJ3BKW2 | 10,231,026 | 450,706 | SH | SOLE | 302,815 | 0 | 147,891 | ||
| CARGO THERAPEUTICS INC | COM | 14179K101 | BBG01D59LY25 | 622,156 | 26,875 | SH | SOLE | 26,875 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | BBG00BC59224 | 8,879,879 | 249,575 | SH | SOLE | 209,240 | 0 | 40,335 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | BBG005NJY3N2 | 4,304,934 | 182,258 | SH | SOLE | 182,258 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | BBG000F0R4N9 | 2,013,027 | 24,111 | SH | SOLE | 24,111 | 0 | 0 | ||
| DISC MEDICINE INC | COM | 254604101 | BBG00W9MJK79 | 7,244,779 | 125,429 | SH | SOLE | 106,197 | 0 | 19,232 | ||
| DISC MEDICINE INC | COM | 254604101 | 371,250 | 1,000 | SH | Call | SOLE | 1,000 | 0 | 0 | ||
| ELI LILLY & CO | COM | 532457108 | BBG000BNBDC2 | 8,782,856 | 15,067 | SH | SOLE | 15,067 | 0 | 0 | ||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | BBG000F90JX5 | 2,212,367 | 95,732 | SH | SOLE | 85,020 | 0 | 10,712 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | BBG000QP35H2 | 3,359,253 | 898,196 | SH | SOLE | 633,516 | 0 | 264,680 | ||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | BBG00DDY1RK9 | 2,541,868 | 376,573 | SH | SOLE | 326,048 | 0 | 50,525 | ||
| IMMATICS N.V | SHS | N44445109 | BBG00VTL2H76 | 10,742,853 | 1,020,214 | SH | SOLE | 780,583 | 0 | 239,631 | ||
| IMMUNOVANT INC | COM | 45258J102 | BBG00P5MC0Q8 | 13,566,492 | 322,015 | SH | SOLE | 263,603 | 0 | 58,412 | ||
| INSMED INC | COM PAR $.01 | 457669307 | BBG000BWM5P3 | 5,379,213 | 173,579 | SH | SOLE | 173,579 | 0 | 0 | ||
| INVESCO QQQ TR | UNIT SER 1 | 46090E103 | BBG01KTLPLD8 | 231,600 | 600 | SH | Put | SOLE | 600 | 0 | 0 | |
| ISHARES TR | ISHARES BIOTECH | 464287556 | BBG012M161Z0 | 360,000 | 2,000 | SH | Put | SOLE | 2,000 | 0 | 0 | |
| ISHARES TR | RUSSELL 2000 ETF | 464287655 | BBG01KMR3H81 | 573,750 | 1,500 | SH | Put | SOLE | 1,500 | 0 | 0 | |
| JASPER THERAPEUTICS INC | CALL | 471871903 | BBG00QPZNP97 | 2,924,910 | 3,707,110 | SH | SOLE | 2,597,198 | 0 | 1,109,912 | ||
| JOHNSON & JOHNSON | COM | 478160104 | BBG000BMHYD1 | 9,562,864 | 61,011 | SH | SOLE | 61,011 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | BBG0026ZG5B0 | 5,183,882 | 423,174 | SH | SOLE | 319,288 | 0 | 103,886 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | BBG00KT2KFX7 | 3,211,609 | 183,102 | SH | SOLE | 183,102 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | BBG006Q52RD0 | 6,752,482 | 108,911 | SH | SOLE | 108,911 | 0 | 0 | ||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | BBG001J2NVH0 | 3,563,433 | 783,172 | SH | SOLE | 520,474 | 0 | 262,698 | ||
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | BBG00TTGH5W4 | 6,296,791 | 104,650 | SH | SOLE | 104,650 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | BBG000QS6NV8 | 4,730,333 | 20,444 | SH | SOLE | 20,444 | 0 | 0 | ||
| MERCK & CO INC | COM | 58933Y105 | BBG000BPD168 | 9,704,524 | 89,016 | SH | SOLE | 89,016 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | BBG00B8LXMS5 | 13,799,665 | 501,806 | SH | SOLE | 413,863 | 0 | 87,943 | ||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | BBG01KBX9P95 | 335,000 | 500 | SH | Put | SOLE | 500 | 0 | 0 | |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | BBG00XQZQTS9 | 10,136,522 | 167,851 | SH | SOLE | 167,851 | 0 | 0 | ||
| MORPHOSYS AG | CALL | 617760902 | BBG00KN74FQ8 | 2,747,102 | 277,485 | SH | SOLE | 277,485 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | BBG000GJS7C1 | 2,964,600 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | BBG001J1BZV0 | 1,247,230 | 279,648 | SH | SOLE | 175,421 | 0 | 104,227 | ||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | BBG00T5JMRT4 | 3,946,457 | 281,287 | SH | SOLE | 245,734 | 0 | 35,553 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | BBG002B63KM7 | 11,778,705 | 513,681 | SH | SOLE | 513,681 | 0 | 0 | ||
| RAPT THERAPEUTICS INC | COM | 75382E109 | BBG00PGK50M2 | 1,452,483 | 58,450 | SH | SOLE | 58,450 | 0 | 0 | ||
| ROIVANT SCIENCES LTD | SHS | G76279101 | BBG007STW2B8 | 24,359,173 | 2,169,116 | SH | SOLE | 1,866,286 | 0 | 302,830 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | BBG0025X16Y5 | 4,730,973 | 218,319 | SH | SOLE | 218,319 | 0 | 0 | ||
| SCPHARMACEUTICALS INC | COM | 810648105 | BBG00J24RT13 | 3,556,413 | 567,211 | SH | SOLE | 567,211 | 0 | 0 | ||
| SHATTUCK LABS INC | COM | 82024L103 | BBG00V776CQ7 | 1,053,472 | 147,752 | SH | SOLE | 147,752 | 0 | 0 | ||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | BBG000BDTBL9 | 4,715,551 | 9,921 | SH | SOLE | 9,921 | 0 | 0 | ||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 286,250 | 1,500 | SH | Put | SOLE | 1,500 | 0 | 0 | ||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 902,250 | 5,000 | SH | Put | SOLE | 5,000 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | BBG0067L94B2 | 8,151,044 | 378,766 | SH | SOLE | 313,378 | 0 | 65,388 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG000R33JY1 | 23,652,015 | 1,094,494 | SH | SOLE | 985,050 | 0 | 109,444 | ||
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | BBG00RB9BNQ7 | 627,548 | 30,990 | SH | SOLE | 30,990 | 0 | 0 | ||
| TEVA PHARMACEUTICAL INDS LTD | CALL | 881624909 | BBG000C0CD58 | 7,324,673 | 701,597 | SH | SOLE | 701,597 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | 2,732,112 | 616,749 | SH | SOLE | 616,749 | 0 | 0 | |||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 6,031,446 | 1,173,433 | SH | SOLE | 976,679 | 0 | 196,754 | ||